Position in ANNX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$19,985,000
-$3,837,000 QoQ
Shares Held
3,500,000
-18.6% QoQ
Ownership
1.71%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#17
of 216 holders
Holding Since
Sep 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ADAGE CAPITAL PARTNERS GP, L.L.C. holds $4,240,035,723 across 126 Biotechnology names. ANNX ranks #51 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
10,349,328 | $366,262,717 | |
| 2 | PRAX |
Praxis Precision Medicines, Inc.
|
1,015,480 | $339,972,549 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
393,964 | $195,693,737 | |
| 4 | TNGX |
Tango Therapeutics, Inc.
|
5,600,000 | $175,056,000 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
2,252,000 | $167,728,960 | |
| 6 | SYRE |
Spyre Therapeutics, Inc.
|
1,722,300 | $152,905,794 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
2,569,356 | $145,965,114 | |
| 8 | RPRX |
Royalty Pharma plc
|
2,500,000 | $140,175,000 |
All Filings in ANNX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,985,000 | 3,500,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $23,822,000 | 4,300,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $27,610,000 | 5,500,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,575,000 | 1,500,000 | Shares | Sole | 2025-11-14 | |
| 2024-09-30 | $16,813,658 | 2,840,145 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $13,916,710 | 2,840,145 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $30,974,220 | 4,319,975 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $22,699,886 | 4,999,975 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,545,941 | 2,349,975 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $8,271,912 | 2,349,975 | Shares | Other | 2023-08-14 | |
| 2023-03-31 | $13,667,403 | 3,549,975 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $18,353,370 | 3,549,975 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $22,204,585 | 3,592,975 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,602,725 | 955,630 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $2,620,335 | 959,830 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $11,028,446 | 959,830 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $18,792,936 | 1,009,830 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $21,605,773 | 959,830 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $28,113,667 | 1,009,830 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $25,276,044 | 1,009,830 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $33,550,160 | 1,109,830 | Shares | Sole | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||